Canine visceral leishmaniasis: Successful chemotherapy induces macrophage antileishmanial activity via the L-arginine nitric oxide pathway

Antimicrobial Agents and Chemotherapy

Volumn 40, Issue 1, 1996, Pages 253-256

  Vouldoukis, Ioannis ^a,e   Drapier, Jean Claude ^b   Nüssler, Andreas K ^c   Tselentis, Yianis ^d   Da Silva, Otamires A ^a   Gentilini, Marc ^a   Mossalayi, Djavad M ^a   Monjour, Loïc ^a   Dugas, Bernard ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b INSTITUT CURIE   (France)

^c UNIVERSITY OF ULM   (Germany)

^d University of Ulm ^*  (Greece)

^e INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIMICROBIAL ACTIVITY; ARTICLE; DOG; IMMUNOSTIMULATION; LEISHMANIA; MACROPHAGE ACTIVATION; NONHUMAN; PRIORITY JOURNAL; VISCERAL LEISHMANIASIS;

EID: 0030052441     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.40.1.253     Document Type: Article

References (23)

1. Abranches, P., G. Santos-Gomes, N. Rachamin, L. Campino, L. F. Schnut, and C. L. Jaffe. 1991. An experimental model for canine visceral leishmaniasis. Parasite Immunol. 13:537-550.
2. Berman, J. D., D. Waddell, and B. D. Hanson. 1985. Biochemical mechanisms of the anti-leishmanial activity of sodium stibugluconate. Antimicrobial. Agents Chemother. 27:916-920.
3. Drapier, J. C., J. Wietzerbin, and J. B. Hibbs. 1989 Interferon-γ and tumor necrosis factor induce the L-arginine-dependent cytotoxic effector mechanism in murine macrophages Eur. J. Immunol. 18:1587-1592
4. Fortier, A. H., D. L. Hoover, and C. A. Nacy. 1982 Intracellular replication of Leishmania tropica in mouse peritoneal macrophages: amastigote infection of resident cells and inflammatory exudate macrophages. Infect Immun 38:1304-1309.
5. Green, L. C., M. S. Meltzer, J. B. Hibbs, and C. A. Nacy. 1990. Activated macrophages destroy intracellular Leishmania major amastigotes by an L-arginine-dependent killing mechanism. J. Immunol. 144:278-285.
6. 15N] nitrate in biological fluids. Anal. Biochem. 126:131-138.
7. Green, S. J., C. A. Nacy, and M. S. Meltzer. 1991. Cytokine-induced synthesis of nitrogen oxides in macrophages: a protective host response to Leishmania and other intracellular pathogens. J. Leukocyte Biol 50:93-103.
8. Harms, G., K. Zwingenherger, B. Sandkamp, S. Omena, C. Pedrosa, J. Richter, F. Rosenkaimer, H. Feldmeier, and U. Bienzle. 1993 Immunochemotherapy of visceral leishmaniasis: a pilot trial of sequential treatment with recombinant interfeion-γ and pentavalent antimony. J. Interferon Res 13: 39-41.
9. Hibbs, J. B., R. R. Taintor, and Z. Vavrin. 1987. Macrophage cytotoxicity: role for L-argininc deiminase activity and imino nitrogen oxidation to nitrite. Science 235:473.
10. Keith, Z., L. Ping, A. Deshratin, C. Manuel, Y. Wen-Chec, E. Violet, F. Laphalle, and M. Joshua. 1993. Production and characterization of recombinant canine interferon-γ from Escherichia coli. J. Interferon Res. 13:91-97
11. Kern, P. 1981. Leishmaniasis Antibiot. Chemother. 30:203-233
12. Liew, F. Y., S. Millot, C. Parkinson, R. M. J. Palmer, and S. Moncada. 1990. Macrophage killing of Leishimania parasites in vivo is mediated by nitric oxide from L-argininc J. Immunol. 144:4794-4797
13. Marletta, M. A., P. S. Yoon, R. Iyengar, C. D. Leaf, and J. S. Wishnok. 1988. Macrophage oxidation of L-arginine to nitrite to nitrate: nitric oxide is an intermediate. Biochemistry 27:8706-8711
14. Murray, H. W. 1988. Interferon-γ, the activated macrophage and host defense against microbial challenge. Ann. Intern. Med. 108:595-608
15. Nacy, C. A., B. J. Nelson, M. S. Melzer, and S. J. Green. 1991. Cytokines that regulate macrophage production of nitrogen oxides and expression of antileishmanial activities. Res. Immunol. 142:573-576.
16. Nathan, C. F., and J. B. Hibbs. 1991. Role of nitric oxide synthesis in macrophage antimicrobial activity Curr. Opin Immunol. 3:65.
17. Neogy, A. B., I. Vouldoukis, J. M. Da Costa, L. Monjour, and the Veterinary Group of Lupino. 1994. Exploitation of parasite-derived antigen in therapeutic success against canine viseral leishmaniosis. Vet. Parasitol. 54:367-373.
18. Nússler, A. K., and T. R. Billiar. 1993. Inflammation, immunoregulation and inducible nitric oxide pathway. J. Leukocyte Biol. 54:171-178.
19. Palmer, R. M. J., and S. Moncada. 1989. A novel citrulline-forming enzyme implicated in the formation of nitric oxide by vascular endothelial cells. Biochem. Biophys Res Comm 158:348-352.
20. Paul-Eugène, N., J. P. Kolb, M. Sarfati, M. Arock, F. Ouaaz, P. Debré, M. D. Mossalayi, and B. Dugas. 1995 Ligation of CD23 activates soluble guanylate cyclase in human monocytes via an L-arginine-dependent mechanism. J. Leukocyte Biol. 57:160-167.
21. Pertoft, H., A. Johnsson, B. Wannegard, and R. Seljelid. 1980. Separation of human monoeytes on density gradients of Percoll. J. Immunol. Methods 33:221-229.
22. Peters, W., and Killick-Kendrick. 1987. The leishmaniasis in biology and medicine, vol. I and II, p. 941-954. Academic Press, Inc , New York.
23. Vouldoukis. I., V. Riveros-Moreno, B. Dugas, F. Ouaaz, P. Bécherel, P. Debré, S. Moncada, and M. D. Mossalayi. 1995. The killing of Leishmania major by human macrophages is mediated by nitric oxide induced after ligation of the FceRII/CD23 surface antigen. Proc. Natl. Acad. Sci. USA 92:7804-7808.